During radiation and chemotherapy, cancer patients including prostate cancer patients, should avoid the routine use of antioxidant supplements unless approved by their doctor. Supplements may reduce the anticancer benefits of therapy, researchers concluded in a commentary published online in the Journal of the National Cancer Institute. Radiation and Taxotere used for advanced prostate cancer therapy [...]
Most of us will experience incontinence to varying degrees no matter what type of primary treatment we elect. If we have surgery, the incontinence will start immediately while those of us whom use radiation therapy will only begin to effected as time goes on. Fortunately, most of us do regain bladder control, some of us [...]
Salvage treatment options for prostate cancer after the failure of radiation as a primary treatment is often seen as a reason to avoid radiation as a primary treatment modality. The common collective wisdom is that after failed radiation our options for additional treatment of recurrent prostate cancer are limited to systematic treatments, hormone therapy, Ketoconazole [...]
Researchers from the Massachusetts General Hospital have reported at the 2008, 99th annual meeting of the American Association for Cancer Research (AACR) in San Diego, April 12-16.1 that Fareston® (toremifene citrate) decreases the risk of new vertebral fractures in men with prostate cancer receiving androgen deprivation therapy (ADT). As we all know from our own [...]
HIFU is becoming increasing popular as a primary alternative treatment for men diagnosed with prostate cancer that is confined in the gland. Commonly used in Europe and in Mexico, HIFU is also being evaluated in a clinical trials in the United States. As with all primary prostate cancer treatments, it too has a failure rate. [...]